Journal of Neurology Neurosurgery and Psychiatry

Papers
(The TQCC of Journal of Neurology Neurosurgery and Psychiatry is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Characteristics of ischaemic stroke associated with COVID-19518
Parkinson’s disease: etiopathogenesis and treatment415
Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials237
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management198
Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke188
TDP-43 proteinopathies: a new wave of neurodegenerative diseases156
Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism137
Ischaemic stroke in young adults: a global perspective118
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions114
Psychological impact on women health workers involved in COVID-19 outbreak in Wuhan: a cross-sectional study111
Primary lateral sclerosis: consensus diagnostic criteria110
Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic108
Brain iron deposition is linked with cognitive severity in Parkinson’s disease108
Pattern of cognitive deficits in severe COVID-1995
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)91
Migraine and risk of stroke91
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 390
Diagnostic and prognostic value of serum NfL and p-Tau181in frontotemporal lobar degeneration88
Central nervous system complications associated with immune checkpoint inhibitors86
Intracerebral implantation of human neural stem cells and motor recovery after stroke: multicentre prospective single-arm study (PISCES-2)86
Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis73
Postinfectious brainstem encephalitis associated with SARS-CoV-273
The future of neuroprotection in stroke73
Outcome measurement in functional neurological disorder: a systematic review and recommendations71
Clinical spectrum of high-titre GAD65 antibodies70
COVID-19–associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network68
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis65
Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019–202065
Occupational therapy consensus recommendations for functional neurological disorder64
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management64
Neuralgic amyotrophy: a paradigm shift in diagnosis and treatment64
Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer’s disease and mild cognitive impairment: a component network meta-analysis64
Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study61
Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis60
Diagnostic and therapeutic aspects of hemiplegic migraine60
Fluid biomarkers in frontotemporal dementia: past, present and future59
Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank58
Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management58
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy57
Decade of progress in motor functional neurological disorder: continuing the momentum57
Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia56
Defining causality in COVID-19 and neurological disorders55
Rituximab in AChR subtype of myasthenia gravis: systematic review52
Anatomy and function of the fornix in the context of its potential as a therapeutic target52
Management of functional communication, swallowing, cough and related disorders: consensus recommendations for speech and language therapy50
Performance validity test failure in clinical populations—a systematic review50
Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK50
Advances in the management of glioblastoma50
Cerebral microbleeds: from depiction to interpretation50
Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key eme48
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders48
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia48
Neurology in the time of COVID-1947
Clinical trials in REM sleep behavioural disorder: challenges and opportunities47
Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS46
Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features46
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis46
A case of limbic encephalitis associated with asymptomatic COVID-19 infection46
Untargeted metabolomics yields insight into ALS disease mechanisms45
Systematic review of psychotherapy for adults with functional neurological disorder45
Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis45
Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease45
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer’s disease: a focused review on recent advances44
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial42
Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study42
LGI1 antibody encephalitis: acute treatment comparisons and outcome41
Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers—a developmental disorder40
Retinal imaging in Alzheimer’s disease40
Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app39
NOTCH3 variants are more common than expected in the general population and associated with stroke and vascular dementia: an analysis of 200 000 participants38
Wilson’s disease: update on pathogenesis, biomarkers and treatments38
Newborn screening for spinal muscular atrophy with disease-modifying therapies: a cost-effectiveness analysis38
Comparison between deep brain stimulation and magnetic resonance-guided focused ultrasound in the treatment of essential tremor: a systematic review and pooled analysis of functional outcomes38
Misdiagnosis of prolonged psychogenic non-epileptic seizures as status epilepticus: epidemiology and associated risks38
Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine37
Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis36
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial36
Neuroinflammation predicts disease progression in progressive supranuclear palsy36
Concussion and long-term cognitive impairment among professional or elite sport-persons: a systematic review35
Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases35
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS35
Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder34
Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients34
Effects of TPH2 gene variation and childhood trauma on the clinical and circuit-level phenotype of functional movement disorders34
Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study33
A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson’s disease: results at the 36-month follow-up33
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register33
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease33
Understanding the relationship between cognitive performance and function in daily life after traumatic brain injury33
Genotype-associated cerebellar profiles in ALS: focal cerebellar pathology and cerebro-cerebellar connectivity alterations32
Systematic clinical approach for diagnosing upper limb tremor32
Multimodal MRI for MRgFUS in essential tremor: post-treatment radiological markers of clinical outcome31
Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen31
Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study31
Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion31
Mental health and suicide in former professional soccer players31
Responsive neurostimulation of the thalamus improves seizure control in idiopathic generalised epilepsy: initial case series30
In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease30
Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies29
Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits29
Early clinical surrogates for outcome prediction after stroke thrombectomy in daily clinical practice28
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias28
Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis28
Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis28
Spectrum of impulse control behaviours in Parkinson’s disease: pathophysiology and management28
Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study28
Suggestibility in functional neurological disorder: a meta-analysis28
Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barré syndrome27
Bilateral staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of essential tremor: a case series study27
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease27
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations27
Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America27
Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA)26
Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation26
Lacunar stroke: mechanisms and therapeutic implications26
Carotid web: an occult mechanism of embolic stroke26
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia26
Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition26
Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis26
Differentiating tic electrophysiology from voluntary movement in the human thalamocortical circuit26
Somatic symptom disorder in patients with post-COVID-19 neurological symptoms: a preliminary report from the somatic study (Somatic Symptom Disorder Triggered by COVID-19)25
Neurofilament light chain and C reactive protein explored as predictors of survival in amyotrophic lateral sclerosis25
Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis25
Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions25
Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration25
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy25
Real-life survey of pitfalls and successes of precision medicine in genetic epilepsies25
Neuropathology and emerging biomarkers in corticobasal syndrome25
Intracranial arterial stenosis in Caucasian versus Chinese patients with TIA and minor stroke: two contemporaneous cohorts and a systematic review24
Clinical features ofNOTCH2NLC-related neuronal intranuclear inclusion disease24
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic24
Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study24
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis24
Impact of mobile stroke units24
Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review24
IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality24
Long-term functional decline of spontaneous intracerebral haemorrhage survivors24
Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension24
Management of patients with generalised myasthenia gravis and COVID-19: four case reports24
Computerised patient-specific prediction of the recovery profile of upper limb capacity within stroke services: the next step24
Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis23
Neurodegenerative disease risk among former international rugby union players23
RFC1-related ataxia is a mimic of early multiple system atrophy23
Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS23
Defining functional brain networks underlying obsessive–compulsive disorder (OCD) using treatment-induced neuroimaging changes: a systematic review of the literature23
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study23
Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis23
Deep brain stimulation of the subthalamic nucleus in obsessive–compulsives disorders: long-term follow-up of an open, prospective, observational cohort23
Frailty, lifestyle, genetics and dementia risk23
COVID-19 impact on consecutive neurological patients admitted to the emergency department23
Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis23
Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data23
Long-term trajectories of decline in cognition and daily functioning before and after stroke22
Pattern of paresis in ALS is consistent with the physiology of the corticomotoneuronal projections to different muscle groups22
Rate of, and risk factors for, white matter hyperintensity growth: a systematic review and meta-analysis with implications for clinical trial design22
Systematic evaluation of genetic mutations in ALS: a population-based study22
Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology22
Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants22
Fronto-striatal circuits for cognitive flexibility in far from onset Huntington’s disease: evidence from the Young Adult Study22
Quality of life in isolated dystonia: non-motor manifestations matter22
Plasma NfL levels and longitudinal change rates in C9orf72 and GRN-associated diseases: from tailored references to clinical applications22
Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects22
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy22
GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance22
Antiglycolipid antibodies in Guillain-Barré and Fisher syndromes: discovery, current status and future perspective21
Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional study21
EEG to detect early recovery of consciousness in amantadine-treated acute brain injury patients21
Factors associated with time to independent walking recovery post-stroke21
Ischaemic stroke in anticoagulated patients with atrial fibrillation21
Split-hand and split-limb phenomena in amyotrophic lateral sclerosis: pathophysiology, electrophysiology and clinical manifestations21
Concussion symptomology and recovery in children and adolescents with pre-existing anxiety21
Cumulative health deficits, APOE genotype, and risk for later-life mild cognitive impairment and dementia20
Antiganglioside antibodies in Guillain-Barré syndrome associated with SARS-CoV-2 infection20
Cognitive reserve in amyotrophic lateral sclerosis (ALS): a population-based longitudinal study20
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS20
Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis20
Relationship between intensity and recovery in post-stroke rehabilitation: a retrospective analysis20
Apathy, but not depression, predicts all-cause dementia in cerebral small vessel disease20
Prevalence of dementia in ischaemic or mixed stroke populations: systematic review and meta-analysis20
Chronic inflammatory demyelinating polyneuropathy associated with diabetes: a European multicentre comparative reappraisal20
Sex differences for phenotype in pathologically defined dementia with Lewy bodies20
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon20
Making sense of phantom limb pain20
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod20
Epilepsy, an orphan disorder within the neurodevelopmental family19
Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes19
Electrical stimulation for seizure induction during SEEG exploration: a useful predictor of postoperative seizure recurrence?19
Post-traumatic epilepsy in adults: a nationwide register-based study19
Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 1919
Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab19
Longitudinal changes of spinal cord grey and white matter following spinal cord injury19
Comparison of efficacy of deep brain stimulation and focused ultrasound in parkinsonian tremor: a systematic review and network meta-analysis19
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis19
Acute ischaemic stroke associated with SARS-CoV-2 infection in North America19
Diffusion imaging in Huntington’s disease: comprehensive review19
Distinct latent profiles based on neurobehavioural, physical and psychosocial functioning of former National Football League (NFL) players: an NFL-LONG Study19
Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis19
Biomarkers in functional movement disorders: a systematic review19
Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs18
Ten-year risks of recurrent stroke, disability, dementia and cost in relation to site of primary intracerebral haemorrhage: population-based study18
In vivo PET imaging of neuroinflammation in familial frontotemporal dementia18
APOE ɛ4dose associates with increased brain iron and β-amyloid via blood–brain barrier dysfunction18
Adoption of focused ultrasound thalamotomy for essential tremor: why so much fuss about FUS?18
Eculizumab versus rituximab in generalised myasthenia gravis18
Association of obesity with disease outcome in multiple sclerosis18
Prevalence, predictors and prognosis of incidental intracranial aneurysms in patients with suspected TIA and minor stroke: a population-based study and systematic review18
Self-injurious behaviour in movement disorders: systematic review17
Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion17
Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes17
Genotype–phenotype correlations in valosin-containing protein disease: a retrospective muticentre study17
CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD17
Risk factors for cognitive impairment in amyotrophic lateral sclerosis: a systematic review and meta-analysis17
Circadian rhythm of ischaemic core progression in human stroke17
Localised increase in regional cerebral perfusion in patients with visual snow syndrome: a pseudo-continuous arterial spin labelling study17
De novo mutations in SOD1 are a cause of ALS17
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab16
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders16
New classification of autoimmune neuropathies based on target antigens and involved domains of myelinated fibres16
Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants16
Location of intracranial aneurysms is the main factor associated with rupture in the ICAN population16
Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer’s disease: an observational clinical study16
Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis15
What is brain fog?15
Intravenous thrombolysis for acute ischaemic stroke during COVID‐19 pandemic in Wuhan, China: a multicentre, retrospective cohort study15
Subjective cognitive complaints at age 70: associations with amyloid and mental health15
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study15
Frequency of MOG-IgG in cerebrospinal fluid versus serum15
Survival after traumatic brain injury improves with deployment of neurosurgeons: a comparison of US and UK military treatment facilities during the Iraq and Afghanistan conflicts15
Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial15
Tissue bridges predict neuropathic pain emergence after spinal cord injury15
Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis15
Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer’s disease15
Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)15
Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosis14
CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study14
Neurofilament light chain predicts future dementia risk in cerebral small vessel disease14
CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer’s disease14
Cognitive inhibition impairments in presymptomatic C9orf72 carriers14
Neuromyelitis optica spectrum disorder: pregnancy-related attack and predictive risk factors14
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study14
Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome14
Regional hyperperfusion in cognitively normal APOE ε4 allele carriers in mid-life: analysis of ASL pilot data from the PREVENT-Dementia cohort14
Great expectations: virus-mediated gene therapy in neurological disorders14
Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis14
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis14
Split hand and motor axonal hyperexcitability in spinal and bulbar muscular atrophy14
Myelin oligodendrocyte glycoprotein-associated disorders are associated with HLA subtypes in a Chinese paediatric-onset cohort14
Clinical profile of fatal familial insomnia: phenotypic variation in 129 polymorphisms and geographical regions14
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis14
Nervous system: subclinical target of SARS-CoV-2 infection14
0.078938007354736